Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Defines Distinct PGx, Cogenic and Diagnostic Units: Mar 1, 2006

NEW YORK, March 1, (GenomeWeb News) - Clinical Data announced today the division of its business into three units.

 

They are PGxHealth, Cogenics, and Vital Diagnostics.

 

The PGX Health division includes assets from newly acquired Genaissance to develop therapeutic diagnostics. The unit is developing CNS, cardiovascular, and oncology tests, the company said in a statement.

 

The Cogenics unit, which represents the combined operations and marketing infrastructure of Genaissance, Lark and Icoria to provide comprehensive pharmacogenomics and molecular services, is developing GLP-validated and research assays.

 

Vital Diagnostics, derived from the operations of Clinical Data, Vital and Electa Labs, is geared toward IVD services for customers in 100 countries.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.